康臣药业(01681)10月16日斥资311.82万港元回购20万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Company Summary - 康臣药业 plans to repurchase 200,000 shares at a total cost of HKD 3.1182 million [1]